Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01139463
What this trial is testing

Study of Blood Lactate Levels in Patients Treated With Antipsychotics

Who this might be right for
Movement DisordersLactic Acidosis
University of Split 60
Post-approval studies (Phase 4)Study completedNCT00659919
What this trial is testing

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

Who this might be right for
Schizophrenia
BeerYaakov Mental Health Center 13
Large-scale testing (Phase 3)WithdrawnNCT00534898
What this trial is testing

Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderCognition
Beersheva Mental Health Center
Large-scale testing (Phase 3)Study completedNCT00161018
What this trial is testing

New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 150
Not applicableUnknownNCT00627757
What this trial is testing

Antipsychotic Medicine and Metabolic Syndrome

Who this might be right for
Metabolic Syndrome
Glostrup University Hospital, Copenhagen 100
Post-approval studies (Phase 4)Study completedNCT00159081
What this trial is testing

One Year Drug Treatment in First-Episode Schizophrenia

Who this might be right for
Schizophrenia
Heinrich-Heine University, Duesseldorf 159
Post-approval studies (Phase 4)Study completedNCT02360319
What this trial is testing

Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics

Who this might be right for
Schizophrenia
Vanguard Research Group 489
Testing effectiveness (Phase 2)Study completedNCT00725075
What this trial is testing

Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 215
Not applicableUnknownNCT06643871
What this trial is testing

Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis

Who this might be right for
Schizophrenia; PsychosisSchizo Affective DisorderFirst Episode Psychosis (FEP)
Centre Hospitalier St Anne 40
Large-scale testing (Phase 3)Study completedNCT01081769
What this trial is testing

Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 769
Not applicableLooking for participantsNCT07817069
What this trial is testing

Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects

Who this might be right for
Treatment Resistant SchizophreniaObesity & OverweightAbdominal Obesity
Faculty of Medicine, Sousse 30
Large-scale testing (Phase 3)Study completedNCT00234377
What this trial is testing

Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 550
Post-approval studies (Phase 4)Study completedNCT03408873
What this trial is testing

CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

Who this might be right for
Bipolar DisorderMedication AdherenceMedication Non Adherence
Martha Sajatovic 30
Not applicableEnded earlyNCT00310661
What this trial is testing

Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Neuroleptic-induced Tardive Dyskinesia
Centre for Addiction and Mental Health 60
Not applicableNot Yet RecruitingNCT05416658
What this trial is testing

Shared Decision Making for Antipsychotic Medications

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders+2 more
New York State Psychiatric Institute 120
Not applicableStudy completedNCT00178958
What this trial is testing

Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffectiveBipolar Disorder
Northwestern University 70
Post-approval studies (Phase 4)Study completedNCT00249171
What this trial is testing

Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Who this might be right for
SchizophreniaPsychotic DisordersEmergency Treatment
Janssen Pharmaceutica N.V., Belgium 226
Not applicableStudy completedNCT00569517
What this trial is testing

Cognitive Behavioral Therapy for Obesity

Who this might be right for
Obesity
US Department of Veterans Affairs 32
Testing effectiveness (Phase 2)Study completedNCT00175955
What this trial is testing

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Medication-induced
UCB Pharma 70
Post-approval studies (Phase 4)UnknownNCT00395915
What this trial is testing

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Universita di Verona 106
Next Page